Johnson & Johnson COVID-19 vaccinations paused
MARSHFIELD – Out of an overabundance of caution, Marshfield Clinic Health System will pause providing the Janssen (Johnson & Johnson) COVID-19 vaccine as recommended by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA).
The CDC and FDA recommended the U.S. pauses the use of the Janssen (Johnson & Johnson) COVID-19 vaccine to investigate six reported U.S. cases of rare and severe blood clots that may be linked to the Janssen COVID-19 vaccine. A total of 6.8 million doses of the Janssen (Johnson & Johnson) COVID-19 vaccine have been given in the U.S. Learn more here.
.
